ZYME

ZYME Stock-Based Compensation

$21.77MTTM · USD

Period ending:

ZYME FY Stock-Based CompUSD
ZYME FY Stock-Based Comp2014-12-31: $574.00K2015-12-31: $1.39M2016-12-31: $4.29M2017-12-31: $3.43M2018-12-31: $13.44M2019-12-31: $49.00M2020-12-31: $29.12M2021-12-31: $10.76M2022-12-31: $4.02M2023-12-31: $8.10M2024-12-31: $17.79M2025-12-31: $28.03M$49.00M$0.00
2014-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ZYME stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.

Zymeworks Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
28,034,000
17,792,000
8,102,000
4,015,000
10,756,000
29,116,000
48,996,000
13,441,000
3,429,000
4,291,000
1,389,000
574,000

Compare stock-based compensation

All ZYME financial metrics · ZYME stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.